23 May 2013
Keywords: colin, booth, joins, oxoid, left, glaxosmithkline, become
Article | 01 July 2002
Colin Booth has left GlaxoSmithKline to become vice president ofscience and technology at Oxoid, a global culture media and diagnostic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 July 2002
© 2013 thepharmaletter.com